189 related articles for article (PubMed ID: 27994861)
1. Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria.
Waziri B; Mabayoje M; Bello B
Clin Kidney J; 2016 Dec; 9(6):817-822. PubMed ID: 27994861
[TBL] [Abstract][Full Text] [Related]
2. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
Qunibi WY
Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
[TBL] [Abstract][Full Text] [Related]
4. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
[TBL] [Abstract][Full Text] [Related]
5. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
Rottembourg J; Rostoker G
Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.
Shepshelovich D; Rozen-Zvi B; Avni T; Gafter U; Gafter-Gvili A
Am J Kidney Dis; 2016 Nov; 68(5):677-690. PubMed ID: 27321965
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously].
Fievet P; Coppin M; Brazier F; Lefèvre M; Stephan R; Demontis R
Nephrol Ther; 2012 Feb; 8(1):41-6. PubMed ID: 21684231
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Goldstein SL; Morris D; Warady BA
Am J Kidney Dis; 2013 Apr; 61(4):588-97. PubMed ID: 23245582
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
Pisani A; Riccio E; Sabbatini M; Andreucci M; Del Rio A; Visciano B
Nephrol Dial Transplant; 2015 Apr; 30(4):645-52. PubMed ID: 25395392
[TBL] [Abstract][Full Text] [Related]
11. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.
Tariq N; Ayub R; Khan WU; Ijaz S; Alam AY
J Coll Physicians Surg Pak; 2015 Mar; 25(3):193-7. PubMed ID: 25772960
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
13. Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group.
Cases A; Puchades MJ; de Sequera P; Quiroga B; Martin-Rodriguez L; Gorriz JL; Portolés J;
Nefrologia (Engl Ed); 2021; 41(2):123-136. PubMed ID: 36166211
[TBL] [Abstract][Full Text] [Related]
14. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
Macdougall IC
Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
[TBL] [Abstract][Full Text] [Related]
15. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
Moorani KN; Asim S
J Ayub Med Coll Abbottabad; 2011; 23(3):47-50. PubMed ID: 23272434
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB
Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534
[TBL] [Abstract][Full Text] [Related]
17. Correction of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study.
Syed A; Bhandari S
QJM; 2016 Mar; 109(3):187-90. PubMed ID: 26101227
[TBL] [Abstract][Full Text] [Related]
18. Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.
Raji YR; Ajayi SO; Akingbola TS; Adebiyi OA; Adedapo KS; Salako BL
Niger Postgrad Med J; 2018; 25(4):197-203. PubMed ID: 30588939
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]